Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_assertion description "[Studies of glioma xenografts suggest that they may be amenable to gene therapy with cytotoxic genes, such as the proapoptotic Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_assertion evidence source_evidence_literature NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_assertion SIO_000772 17178885 NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_assertion wasDerivedFrom befree-2016 NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_assertion wasGeneratedBy ECO_0000203 NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.
- befree-2016 importedOn "2016-02-19" NP585105.RA9NYQ84uwkwqUf_4eB4q2EBLcCbZhxIcqoLcUD_8mx2Q130_provenance.